For example, androgens attach to special receptors on the surface of prostate cancer cells, which enables the cells to send ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...

Until about 15 years ago, most men diagnosed with prostate cancer — no matter how aggressive — underwent surgery or radiation ...

This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...

Patients with a certain form of aggressive prostate cancer could benefit from a new combination of drugs which slow cancer ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on disease progression. Among patients with intermediate-risk prostate cancer, ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

According to the CDC, prostate cancer represents the most common non-skin cancer in American men and the second leading cause of death in US men. Recent research initiatives have shed some light on ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease.

The travel writer and host of 'Rick Steves Europe' shares an update after prostate cancer diagnosis to encourage men to 'say ...